PuSH - Publication Server of Helmholtz Zentrum München

Matthes, S.* ; Stadler, J.* ; Barton, J.* ; Leuschner, G.* ; Munker, D.* ; Arnold, P.* ; Villena-Hermoza, H.* ; Frankenberger, M. ; Probst, P.* ; Koch, A.* ; Kneidinger, N.* ; Milger, K.* ; Behr, J.* ; Neurohr, C.*

Asthma features in severe COPD: Identifying treatable traits.

Respir. Med. 145, 89-94 (2018)
Publ. Version/Full Text Postprint DOI PMC
Open Access Green
Aim: Biological therapies developed for severe asthma may have a role in COPD patients with asthma features.Method: We carried out a prospective, consecutive, cross-sectional analysis of 80 patients with severe COPD GOLD IV/D.Results: We studied 80 patients (48.8% female), aged 57.6 +/- 5.1 years, ex-smokers with 35.7 +/- 21.2 pack years, BMI 22.3 +/- 3.5 kg/m(2), FEV1 of 0.61 +/- 0.2 L (21.1 +/- 5.6% pred), pO(2) 52.4 +/- 8.4 mmHg, and BODE 6.9 +/- 1.7. 68% had > 2 moderate or severe exacerbations annually. 16.1% (5/31) patients showed FEV1 reversibility of > 12% and > 200 ml despite maximal therapy, 33% (15/45) had FENO >= 22.5 ppb, 33% (24/73) had serum IgE >= 100 I.E./ml and there was positive allergen sensitization in 51.5% (35/68). Blood eosinophilia of >= 150 cells/mu l was seen in 47% (35/74). Induced sputum showed eosinophilia of >= 2% in 56% (14/24) with respiratory pathogens in 63.8% (30/47). We identified 12 (15%) patients with asthma-COPD overlap. Of these, 10 (83.3%) had frequent exacerbations and these patients had significantly more severe exacerbations requiring NIV or ICU than those without asthma features (p < 0.005).Conclusion: We detected asthma features in a substantial subset of stable patients with severe COPD. Asthma features were associated with more severe exacerbation despite optimal COPD therapy, representing potential candidates for targeted therapy with anti- IgE or anti-IL5.
Altmetric
Additional Metrics?
[➜Log in]
Edit extra informations Login
Publication type Article: Journal article
Document type Scientific Article
Corresponding Author
Keywords Copd ; Exacerbations Of Copd ; Asthma And Copd Overlap ; Targeted Therapy; Obstructive Pulmonary-disease; Overlap Syndrome; Blood Eosinophils; Exacerbations; Sputum; Inflammation
ISSN (print) / ISBN 0954-6111
e-ISSN 1532-3064
Journal Respiratory Medicine
Quellenangaben Volume: 145, Issue: , Pages: 89-94 Article Number: , Supplement: ,
Publisher Elsevier
Publishing Place 32 Jamestown Rd, London Nw1 7by, England
Non-patent literature Publications
Reviewing status Peer reviewed
Institute(s) Lung Health and Immunity (LHI)